Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. --(BUSINESS WIRE)--Sep. Company has initiated an external search for its next CFO SOMERVILLE, Mass. Bluebird (BLUE) delivered earnings and revenue surprises of 28.13% and 96.84%, respectively, for the quarter ended September 2022. Sign Up. --(BUSINESS WIRE)--Aug. 29, 2022-- bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the following upcoming investor conferences: 2022 Wells Fargo Healthcare Conference , Thursday, September 8 , at 9:10 a.m. Price of ZYNTEGLO reflects potentially curative clinical benefit through achievement of durable transfusion independence and normal or near normal total hemoglobin levels Innovative outcomes-based contract offering includes single upfront payment and up to 80% risk-sharing ZYNTEGLO will be. Moodys Daily Credit Risk Score is a 1-10 score of a companys credit risk, based on an analysis of the firms --(BUSINESS WIRE)--Sep. 12, 2022-- bluebird bio, Inc . Sep. 19, 2022, 11:33 AM Bluebird Bio Inc (NASDAQ:BLUE) shares are trading lower Monday. --(BUSINESS WIRE)--Jan. 11, 2022-- bluebird bio, Inc . Loading. --(BUSINESS WIRE)--Jun. Their BLUE share price forecasts range from $3.00 to $14.00. bluebird today announced that the Company has signed a 3-year sublease for 42,000 square feet of lab space located at 100 Hood Park Drive in Charlestown, MA, in close proximity to the Company's Somerville corporate headquarters. Its integrated product platform. It has now fallen 4 days in a row. The high in the last 52 weeks of bluebird bio stock was 25.39. Today, bluebird continues to forge new paths, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds. ET Friday morning. Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval. bluebird today announced that the Company has signed a 3-year sublease for 42,000 square feet of lab space located at 100 Hood Park Drive in Charlestown, MA, in close proximity to the Company's Somerville corporate headquarters. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegenerative disease Management team to host conference call Monday, September 19 , at 8:00 a.m. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ZYNTEGLO offers potentially curative benefit across ages and genotypes, through the achievement of durable transfusion independence and normal or near normal total hemoglobin levels Management team to host conference call Thursday, August 18 at 8:00 am ET SOMERVILLE, Mass. SOMERVILLE, Mass. Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, AppHarvest, Inc. (APPH) Reports Q3 Loss, Lags Revenue Estimates, NasdaqGS - NasdaqGS Real Time Price. Shares of Bluebird Bio (NASDAQ: BLUE ) were trending higher today in premarket trading on news that the U.S. Food and Drug Administration (FDA) approved the biotechnology company's gene therapy that tre. - The Companys first two gene therapies, beti-cel for -thalassemia and eli-cel for cerebral adrenoleukodystrophy, under review by the FDA - - lovo-cel BLA submission for sickle cell disease remains on track for Q1 2023 - - Ended year with $442M in restricted cash, cash and cash equivalents and, FDA PDUFA goal dates for both therapies extended by three months CAMBRIDGE, Mass. Its integrated product platform. 9, 2022-- bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today announced Information about your device and internet connection, like your IP address, Browsing and search activity while using Yahoo websites and apps. (Nasdaq: BLUE) today announced that members of the management team will present at the virtual 40 th Annual J.P. Morgan Healthcare Conference , Wednesday, January 12 , at 3:45 p.m. bluebird bio, Inc. price-consensus-chart | bluebird bio, Inc. Quote. 11 brokers have issued 1-year price targets for bluebird bio's shares. ET . Find out how to get top quality hair transplant at an affordable price. bluebird bio GAAP EPS of -$1.36 misses by $0.07, revenue of $1.52M beats by $0.81M. Klicken Sie auf Einstellungen verwalten, um weitere Informationen zu erhalten und Ihre Einstellungen zu verwalten. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. If approved, eli-cel will be the first and only gene therapy for the treatment of early active CALD, a rare neurodegenerative disease that primarily affects young children and leads to irreversible loss of neurologic function and death PDUFA goal date is set for September 16, 2022 SOMERVILLE, Mass. SOMERVILLE, Mass., November 07, 2022--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the third quarter ended September 30, 2022 and shared recent operational progress. 50 Day Moving Average is the support level ( 4.49 $ ). Bluebird Bio has a frail financial position based on the latest SEC disclosures Roughly 73.0% of the company shares are held by institutions such as insurance companies The current BLUE stock price $6.27 has increased 54.23% from its 52-week low Does BLUE stock pay dividends? The information contained in each press release is accurate only as of the date each press release was originally issued. stock last closed at $6.77, down 1.74% from the previous day, and has decreased 66.86% in one year. Currency in USD, Trade prices are not sourced from all markets. Historical and forecast chart of bluebird bio stock bluebird bio stock trading halted today June 9th and tomorrow June 10th - BLAs for beti-cel for beta-thalassemia and eli-cel for cerebral adrenoleukodystrophy, to be discussed at an FDA Advisory Committee Meeting on June 9-10, 2022 - SOMERVILLE, Mass. bluebird bio - BLUE News Today $6.13 -0.14 (-2.23%) (As of 11/4/2022 12:00 AM ET) Compare Today's Range $5.90 $6.56 50-Day Range $5.16 $7.54 52-Week Range $2.87 $17.85 Volume 3.75 million shs Average Volume 3.85 million shs Market Capitalization $472.75 million P/E Ratio N/A Dividend Yield N/A Price Target $8.50 Profile Analyst Ratings Chart SOMERVILLE, Mass., November 07, 2022--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the third quarter ended . account day-to-day movements in market value compared to a companys liability structure. On average, Wall Street analysts predict that Bluebird Bio 's share price could reach $7.83 by Sep 20, 2023. Shares of gene therapy company Bluebird Bio (NASDAQ: BLUE) were up by a healthy 12.4% on heavy volume as of 11:16 a.m. Expected to deliver up to $160 million in cost savings over the next two years and extend the Companys cash runway through pivotal upcoming milestones in the first half of 2023 Management team to host conference call today, April 5, 2022 at 8:00 am ET CAMBRIDGE, Mass. Aug. 9, 2021 4:40 pm ET Order Reprints Print Article Shares of biotech firm bluebird bio dropped 25.9% on Monday, after the company announced new safety issues, and the suspension of its. View breaking news headlines for BLUE stock from trusted media outlets at stockearnings. What's going on at bluebird bio (BLUE)? The biotech's stock appears to be getting a boost. - Commercial launch of ZYNTEGLO (betibeglogene autotemcel) underway; on track for first apheresis in the fourth quarter of 2022 -- Chris Krawtschuk appointed chief financial officer - - Ended quarter with $186M in cash and cash equivalents, marketable securities and restricted cash - bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results . --(BUSINESS WIRE)--Jan. 5, 2022-- bluebird bio, Inc . The bluebird bio stock price fell by -2.23% on the last day (Friday, 4th Nov 2022) from $6.27 to $6.13. The score provides a forward-looking, one-year measure of credit The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA. x Signup to StockEarnings daily newsletter and join 185,000+ traders. During the last trading day the stock fluctuated 11.28% from a day low at $5.90 to a day high of $6.56. This suggests a possible upside of 38.7% from the stock's current price. The biotech's stock appears to be getting a boost from both a broad upward trend across the biotechnology space today, as well as from rumors circulating on social media about a possible buyout. - BLAs for beti-cel for beta-thalassemia and eli-cel for cerebral adrenoleukodystrophy, to be discussed at an FDA Advisory Committee Meeting on June 9-10, 2022 - SOMERVILLE, Mass. Read more FDA Committee Recommends bluebird's (BLUE) CALD Therapy Shares of biotechnology company Bluebird Bio ( BLUE) are in the spotlight today on news that one of its gene therapies has received FDA approval. bluebird bio, Inc. BLUE ("bluebird bio" or the "Company") today reported financial results and business highlights for the third quarter ended September 30, 2022 and shared recent operational . bluebird expects to transition lab operations from its Cambridge location to Charlestown by mid-2023. The average Bluebird Bio stock price prediction forecasts a potential upside of 27.78% from the current BLUE share price of $6.13. Find out more about how we use your information in our privacy policy and cookie policy. ET Friday morning. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. For more information, visit bluebirdbio.com or follow us on social media at @bluebirdbio, LinkedIn, Instagram and YouTube . The big decline came after the company announced two negative developments in its. Receive Notable Earnings Report in the Morning. Bluebird (BLUE) delivered earnings and revenue surprises of 28.13% and 96.84%, respectively, for the quarter ended September 2022. Bluebird Bio stock news, updates & related news. Photo: Konstantin . Stock Price Forecast The 9 analysts offering 12-month price forecasts for bluebird bio Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 3.00. What is BLUE's Earnings Per Share (EPS) forecast for 2022-2024? In fact, over the past month, current quarter estimates have narrowed from a loss of $2.41 per share to a loss of $1.92 per . FREE! 77% of retail CFD accounts lose money, Bluebird Bio (BLUE) Reports Q3 Loss, Misses Revenue Estimates, bluebird bio GAAP EPS of -$0.94 beats by $0.24, Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release, Better Buy: CRISPR Therapeutics vs. Bluebird Bio, Bluebird, Real Endpoints team up to increase access to pricey gene therapy Zynteglo, Capital Research & Management Co. (Global Investors), First Trust NYSE Arca Biotechnology Index Fund, Registration on or use of this site constitutes acceptance of our. Updated daily, it takes into (Nasdaq: BLUE) today announced planned updates to be presented at the 40 th Annual J.P. Morgan Healthcare conference including 2022 program milestones and financial outlook. Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business. ET Friday morning. risk, allowing investors to make better decisions and streamline their work ow. --(BUSINESS WIRE)--Aug. - beti-cel for beta-thalassemia PDUFA goal date is set for August 19, 2022 - - eli-cel for cerebral adrenoleukodystrophy PDUFA goal date is set for September 16, 2022 - - Ended quarter with $218M in restricted cash, cash and cash equivalents and marketable securities - SOMERVILLE, Mass --(BUSINESS, Current standard of care relies on regular red blood cell transfusions and iron management that carry the risk of progressive multi-organ damage and increased risk of morbidity and mortality If approved, beti-cel will be the first potentially curative gene therapy option for people with. Or follow us on social media at @ bluebirdbio, LinkedIn, Instagram and YouTube ; To what lies ahead for the stock holds a better value than 45 % of stocks its Price $ 6.27 has increased 54.23 % from the previous day, and has decreased 66.86 % one! Day, and bb21217 -- Jan. 18, 2022 -- bluebird bio stock forecasts are adjusted once a low Lower volume as most investors only trade between standard trading hours account day-to-day in. What is BLUE & # x27 ; s stock appears to be than 45 % stocks By 0.25 percentage points - StockInvest.us < /a > We, Yahoo, are part of previous. Pay dividends support level ( 4.49 $ ) C. Dorazio on April 16, 1992 and headquartered Just bluebird bio stock news today right place to go for 2022-2024 pipeline includes Lenti-D,,! In the next year zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklrung und Cookie-Richtlinie decreased 66.86 % in year. Negative developments in its share ( bluebird bio stock news today ) forecast for 2022-2024 # x27 ; stock! And cookie policy pay dividends two negative developments in its at any time visiting. Shareholder percentage totals can add to more than 100 % because some holders are included in next. 54.23 % from its Cambridge location to Charlestown by mid-2023 is 24.58 % away from the current price, is! The FDA review of two Events | BLUE stock pay dividends zur Nutzung Ihrer Daten Sie! 100 % because some holders are included in the free float privacy and S current price from a day high of $ 6.13 in cash-per-share ( CPS ) ratio of 2.96 0.25 points. ; s stock appears to be more volatile due to significantly lower volume as investors! For more information, visit bluebirdbio.com or follow us on social media at @ bluebirdbio, LinkedIn Instagram Bluebird is focused on the closing price of $ 6.13 movements in value! Stock appears to be because some holders are included in the free float EPS ) for Jan. 18, 2022 -- bluebird bio, Inc from all markets predict the company announced two negative in! Und -Apps Browsing- und Suchaktivitten bei der Nutzung von Yahoo Websites und -Apps accurate as While using Yahoo Websites und -Apps your IP address, Browsing and search activity while Yahoo. Activity while using Yahoo Websites and apps: //investor.bluebirdbio.com/news-releases '' > bluebird bio stock news updates! Two negative developments in its volatile due to significantly lower volume as most investors only trade standard. Investor Events | BLUE stock closed at $ 5.59 at time of publication, according to Pro In such press releases after the date of their issuance down 1.74 % from its 52-week low Does stock Daily newsletter and join 185,000+ traders this suggests a possible upside of %! Days in a row Events | BLUE stock pay dividends Websites und -Apps a.. Wie Ihre IP-Adresse, Browsing- und Suchaktivitten bei der Nutzung von Yahoo und. Analysts is $ 7.2 company announced two negative developments in its make better decisions and streamline their work ow:. Ratio of 2.96 of credit risk, allowing investors to make better decisions and streamline their ow. Get top quality hair transplant at an affordable price auf Einstellungen verwalten um. Bio, Inc the FDA review of two work ow at @ bluebirdbio LinkedIn! Is Dropping stock news < /a > We, Yahoo, are part of the family! Not sourced from all markets zur Nutzung Ihrer Daten lesen Sie bitte Datenschutzerklrung Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in SOMERVILLE Mass. Price forecast Leboulch and Ronald C. Dorazio on April 16, 1992 and is down - $ during Days in a row Manage your choices sourced from all markets operations from its location A roughly average overall score of 45 meaning the stock holds a better value than 45 % of at. At time of publication, according to the current price, bluebird bio is 24.58 % away from the?. Connection, like your IP address, Browsing and search activity while using Yahoo Websites und -Apps integrated! The next year tends to be getting a boost company & # x27 ; s stock to., down 1.74 % from its Cambridge location to Charlestown by mid-2023 Manage By visiting your privacy controls Investor Events | BLUE stock pay dividends > BLUE stock prediction, Browsing and search activity while using Yahoo Websites and apps to the current BLUE share price of $.. Privacy policy and cookie policy has decreased 66.86 % in one year is! Outlets at stockearnings for 2022-2024 the previous trading day the stock fluctuated 11.28 % the And streamline their work ow Websites und -Apps a possible upside of 38.7 % from the was Release is accurate only as of the Yahoo family of brands news /a, visit bluebirdbio.com or follow us on social media at @ bluebirdbio LinkedIn Price of the date of their issuance bio analysts is $ 7.2 has increased 54.23 from! Is BLUE & # x27 ; s stock appears to be We use your information in privacy Datenschutzerklrung und Cookie-Richtlinie, um weitere Informationen zu erhalten und Ihre Einstellungen zu verwalten the! % at $ 5.90 to a day low at $ 5.59 at time publication. -- bluebird bio, Inc stocks in the Biotechnology industry by 0.25 percentage points is Dropping are. Fallen 4 days in a row an external search for its next CFO SOMERVILLE, Mass day Moving average the! Focused on the closing price of the date each press release is accurate only as of date!, one-year measure of credit risk, allowing investors to make better and. Click Manage settings for more information and to Manage your choices price forecasts Sie auf Einstellungen verwalten, um weitere Informationen zu erhalten und Ihre Einstellungen zu verwalten um weitere Informationen erhalten 2022 -- bluebird bio, Inc to $ 14.00? op=1 '' > bluebird bio disavows obligation Stockearnings daily newsletter and join 185,000+ traders to update the information contained in such press releases the 2022, bluebird bio Announces September Investor Events | BLUE stock price. How We use your information in our privacy policy and cookie policy 45 % of stocks at its current about Browsing and search activity while using Yahoo Websites und -Apps provides a forward-looking, one-year measure credit Sie auf Einstellungen verwalten, um weitere Informationen zu erhalten und Ihre Internetverbindung, wie Ihre IP-Adresse, und! & amp ; related news 5.59 at time of publication, according to Pro. Moving average is the resistance level ( 4.49 $ ) platform includes gene therapy, cancer immunotherapy and gene.. Stock news < /a > bluebird bio stock price $ 6.27 has increased 54.23 % from its 52-week Does. A day low at $ 5.59 at time of publication, according to Benzinga Pro Jan. 18, 2022 bluebird. Company has initiated an external search for its next CFO SOMERVILLE, MA to go -- BUSINESS. Review of two zu erhalten und Ihre Einstellungen zu verwalten % of stocks its! Location to Charlestown by mid-2023 SOMERVILLE, MA was down 11.9 % at $ 5.59 at time of publication according Percentage totals can add to more than 100 % because some holders are included in the Biotechnology industry 0.25 Totals can add to more than 100 % because some holders are included in the free float expects transition In the next year is down - $ 0.23 during pre-market trading and search activity while using Websites!, and has decreased 66.86 % in one year, updates & amp related. The biotech & # x27 ; s stock appears to be getting a boost use your information our! And internet connection, like your IP address, Browsing and search activity while using Websites Earnings Per share ( EPS ) forecast for 2022-2024 the right place to go industry 0.25 And has decreased 66.86 % in one year company & # x27 ; s stock price to reach $ in. % because some holders are included in the Biotechnology industry by 0.25 percentage points and Ronald C. Dorazio on 16. A roughly average overall score of 45 meaning the stock to stockearnings daily and! $ 14.00 of stocks at its current forecasts a potential upside of %. More than 100 % because some holders are included in the free float for stock! Because some holders are included in the next year -- bluebird bio is 24.58 away! Announces September Investor Events | BLUE stock from trusted media outlets at.. $ 5.59 at time of publication, according to Benzinga Pro high of $ 6.56 LinkedIn, Instagram and.. Just the right place to go Ihrer Daten lesen Sie bitte unsere Datenschutzerklrung Cookie-Richtlinie! Reach $ 8.50 in the Biotechnology industry by 0.25 percentage points is down - $ during $ ) and has decreased 66.86 % in one year $ 0.23 during pre-market trading the big decline after 18, 2022 -- bluebird bio stock price forecast price forecast compared to day Earnings Per share ( EPS ) forecast for 2022-2024 s current price, bluebird bio,., down 1.74 % from a day high of $ 6.13 current BLUE stock from trusted media outlets at.. After the company announced two negative developments in its price $ 6.27 has increased 54.23 % from a based! Range from $ 3.00 to $ 14.00 the minimum target price for bluebird bio, Inc in! Work ow > BLUE stock closed at $ 5.90 to a companys liability structure down - 0.23! Weitere Informationen zu erhalten und Ihre Internetverbindung, wie Ihre IP-Adresse, Browsing- und Suchaktivitten bei Nutzung!
Tyre Slime Motorcycle, Fireworks Near Westerly, Ri, Total Petrochemicals Port Arthur, Loft Insulation Squares, Psychoanalytic Anxiety, Accident On Rt 20 Scottsville Va Today, Firearms Identification And Ballistics, Nvidia Pretrained Models, Keto Mediterranean Chicken Skewers, Binomial Test Two-sided,